- Filed
- May 12, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $1.07B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $977M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $16.67M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $16.58M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $26.23M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $22.82M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $558.14M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $467.79M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $150.61M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $174.8M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.33B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.26B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $119.76M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $118.27M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $2.43B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.36B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 10.98M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $16.4M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $43.62M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $11.47 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $12.05 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $14.79M |
| Net Income | Q1 2025 · Mar 31, 2024 | $129.16M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $30.18M |
| Revenue | Q1 2025 · Mar 31, 2024 | $118.87M |